Literature DB >> 15171567

Oximes-induced reactivation of rat brain acetylcholinesterase inhibited by VX agent.

Kamil Kuca1, Jirí Kassa.   

Abstract

A comparison of one mono- and seven bisquaternary acetylcholinesterase (AChE) reactivators of acetylcholinesterase inhibited by VX agent was performed. As a source of the acetylcholinesterase, a rat brain homogenate was taken. There were significant differences in reactivation potency of all tested oximes. The oxime TO205 seems to be the most efficacious followed by TO046, HI-6, HS-6, K027, obidoxime, MMC and 2-PAM. In addition, the results of this study showed that the reactivation potency of the tested reactivators depends on many factors--such as the number of pyridinium rings, the number of oxime groups and their position, as well as the length and the shape of linkage bridge between two pyridinium rings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15171567     DOI: 10.1191/0960327104ht434oa

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  3 in total

1.  Reactivation of organophosphate-inhibited acetylcholinesterase by quaternary pyridinium aldoximes.

Authors:  Kamil Kuca; Jirí Patocka; Jirí Cabal; Daniel Jun
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase.

Authors:  Kamil Kuca; Kamil Musilek; Daniel Jun; Jana Zdarova-Karasova; Eugenie Nepovimova; Ondrej Soukup; Martina Hrabinova; John Mikler; Tanos C C Franca; Elaine F F Da Cunha; Alexandre A De Castro; Martin Valis; Teodorico C Ramalho
Journal:  BMC Pharmacol Toxicol       Date:  2018-02-21       Impact factor: 2.483

Review 3.  The Experimental Oxime K027-A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime.

Authors:  Dietrich E Lorke; Georg A Petroianu
Journal:  Front Neurosci       Date:  2019-05-22       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.